BRCA Testing for Genetic Breast Cancer/Ovarian Cancer | Dr. Shona Nag

Sdílet
Vložit
  • čas přidán 11. 09. 2024
  • Could a simple test save your life? Well Yes, BRCA testing could be the key to unlocking your genetic risks for breast and ovarian cancer. Understanding your risk for genetic breast cancer & ovarian cancer can be life-changing.
    Dr. Shona Nag, Senior Medical Oncologist and Director of the Oncology Department at Sahyadri Hospitals, Pune, explains the importance of BRCA screening. She breaks down how a BRCA mutation test can help identify potential risks early, giving you the power to make informed decisions about your health.
    If breast or ovarian cancer runs in your family, or if you’ve been diagnosed with cancer at a young age, BRCA screening might be crucial for you. Dr. Nag breaks down who should consider BRCA gene testing, how the process works, and how the results can lead to personalized treatment options that can make all the difference.
    Empower yourself with knowledge -- Learn more about BRCA testing and how it could be your best defense against BCRA gene-associated cancers.
    If you found this video helpful, like, share, and subscribe for more expert insights on cancer prevention and care.
    ---------------------------------------------
    🩺Book a Free Genetic Counseling session with our experts here: diagnostics.me...
    ✅ Explore Our Resources:
    Blogs: diagnostics.me...
    Patient Stories: diagnostics.me...
    Press Media Mentions: diagnostics.me...
    👍Follow and Like us on:
    Instagram: / medgenome
    Facebook: / medgenomelabs
    Twitter: x.com/medgenom...
    LinkedIn: / medgenomelabs
    🤝Connect With Us:
    Email: diagnostics@medgenome.com
    Toll-free number: 1800 296 9696
    ⬇️Download Our Application:
    Android: bit.ly/3yYVvAb
    iOS: bit.ly/4cxRikU
    #brcatesting #brcamutationtesting #brcascreening #brcageneandbreastcancer #brcagenetesting #brcageneassociatedcancers #brcatestingforbreastcancer #brcatestingforovariancancer #brcagenemutations #brca1andbrca2testing #inheritedbreastcancer #geneticbreastcancer #brcamutations #MedGenome #Geneticcounseling #DrShonaNag
    ---------------------------------------------
    About MedGenome
    MedGenome is a global leader in genetic testing services, genomics research, and drug discovery solutions. Since 2013, we have been committed to delivering world-class genomic solutions with precision and accuracy, empowering every individual to manage their health better.
    We are proud to be the only CAP-accredited genetic testing lab in India, offering 1300+ genetic tests backed by the latest and most advanced technologies available worldwide. MedGenome is dedicated to providing the best precision testing solutions for quicker and smarter diagnosis of complex diseases.
    Our Mission
    We are on a mission to democratize access to quality and affordable genetic solutions, serving over 4 billion people for their healthcare needs through the power of genetic testing.
    Our Expertise
    We operate Southeast Asia's largest CAP-accredited Next Generation Sequencing (NGS) lab, equipped with cutting-edge genome sequencing platforms such as Illumina’s NovaSeq, HiSeq X, MiSeq, and more. Our team consists of expert molecular biologists, geneticists, data scientists, and bioinformaticians driving our genomics research.
    As a firm believer in quality, MedGenome adheres to the highest international standards in our services and has obtained the prestigious CAP accreditation for our main lab in Bangalore.
    At MedGenome, we continue to push the boundaries of genetic research, providing insights into complex diseases and driving innovation in personalized medicine.
    ---------------------------------------------
    Disclaimer:
    The content provided in this video is intended solely for educational purposes. It should not be used as a substitute for professional medical advice, diagnosis, or treatment. If you have any concerns, please consult a qualified healthcare provider. MedGenome accepts no liability for individual interpretations of the content, although it is accurate to the best of our knowledge at the time of publication.

Komentáře •